Authors:
WHEELER DA
GIBERT CL
LAUNER CA
MUURAHAINEN N
ELION RA
ABRAMS DI
BARTSCH GE
Citation: Da. Wheeler et al., WEIGHT-LOSS AS A PREDICTOR OF SURVIVAL AND DISEASE PROGRESSION IN HIV-INFECTION, Journal of acquired immune deficiency syndromes and human retrovirology, 18(1), 1998, pp. 80-85
Authors:
BROSGART CL
LOUIS TA
HILLMAN DW
CRAIG CP
ALSTON B
FISHER E
ABRAMS DI
LUSKENHAWK RL
SAMPSON JH
WARD DJ
THOMPSON MA
TORRES RA
Citation: Cl. Brosgart et al., A RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF THE SAFETY AND EFFICACY OF ORAL GANCICLOVIR FOR PROPHYLAXIS OF CYTOMEGALOVIRUS DISEASE IN HIV-INFECTED INDIVIDUALS, AIDS, 12(3), 1998, pp. 269-277
Authors:
SLOME LR
MITCHELL TF
CHARLEBOIS E
BENEVEDES JM
ABRAMS DI
Citation: Lr. Slome et al., PHYSICIAN-ASSISTED SUICIDE AND PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE, The New England journal of medicine, 336(6), 1997, pp. 417-421
Citation: Jh. Burack et al., PILOT RANDOMIZED CONTROLLED TRIAL OF CHINESE HERBAL TREATMENT FOR HIV-ASSOCIATED SYMPTOMS, Journal of acquired immune deficiency syndromes and human retrovirology, 12(4), 1996, pp. 386-393
Authors:
BROSGART CL
MITCHELL T
CHARLEBOIS E
COLEMAN R
MEHALKO S
YOUNG J
ABRAMS DI
Citation: Cl. Brosgart et al., OFF-LABEL DRUG-USE IN HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE, Journal of acquired immune deficiency syndromes and human retrovirology, 12(1), 1996, pp. 56-62
Authors:
GOLDMAN AI
CARLIN BP
CRANE LR
LAUNER C
KORVICK JA
DEYTON L
ABRAMS DI
Citation: Ai. Goldman et al., RESPONSE OF CD4 LYMPHOCYTES AND CLINICAL CONSEQUENCES OF TREATMENT USING DDI OR DDC IN PATIENTS WITH ADVANCED HIV-INFECTION, Journal of acquired immune deficiency syndromes and human retrovirology, 11(2), 1996, pp. 161-169
Citation: Rj. Leiser et al., THE ROLE OF CRITICAL CARE NURSES IN EUTHANASIA AND ASSISTED SUICIDE, The New England journal of medicine, 335(13), 1996, pp. 972-973
Authors:
NORTHFELT DW
CHARLEBOIS ED
MIRDA MI
CHILD C
KAPLAN LD
ABRAMS DI
Citation: Dw. Northfelt et al., CONTINUOUS LOW-DOSE INTERFERON-ALPHA THERAPY FOR HIV-RELATED IMMUNE THROMBOCYTOPENIC PURPURA, Journal of acquired immune deficiency syndromes and human retrovirology, 8(1), 1995, pp. 45-50
Citation: Di. Abrams et al., MARIJUANA, THE AIDS WASTING SYNDROME, AND THE US GOVERNMENT, The New England journal of medicine, 333(10), 1995, pp. 671-671
Authors:
NEATON JD
WENTWORTH DN
RHAME F
HOGAN C
ABRAMS DI
DEYTON L
Citation: Jd. Neaton et al., CONSIDERATIONS IN CHOICE OF A CLINICAL END-POINT FOR AIDS CLINICAL-TRIALS, Statistics in medicine, 13(19-20), 1994, pp. 2107-2125
Authors:
ABRAMS DI
GOLDMAN AI
LAUNER C
KORVICK JA
NEATON JD
CRANE LR
GRODESKY M
WAKEFIELD S
MUTH K
KORNEGAY S
COHN DL
HARRIS A
LUSKINHAWK R
MARKOWITZ N
SAMPSON JH
THOMPSON M
DEYTON L
Citation: Di. Abrams et al., A COMPARATIVE TRIAL OF DIDANOSINE OR ZALCITABINE AFTER TREATMENT WITHZIDOVUDINE IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, The New England journal of medicine, 330(10), 1994, pp. 657-662
Citation: S. Oie et al., ALPHA(1)-ACID GLYCOPROTEIN LEVELS IN AIDS PATIENTS BEFORE AND AFTER SHORT-TERM TREATMENT WITH ZIDOVUDINE (ZDV), Journal of acquired immune deficiency syndromes, 6(5), 1993, pp. 531-533
Authors:
ABRAMS DI
MITCHELL TF
CHILD CC
SHIBOSKI SC
BROSGART CL
MASS MM
Citation: Di. Abrams et al., CLOFAZIMINE AS PROPHYLAXIS FOR DISSEMINATED MYCOBACTERIUM-AVIUM COMPLEX INFECTION IN AIDS, The Journal of infectious diseases, 167(6), 1993, pp. 1459-1463